Asana Medical, Inc. to Exhibit at Gold Coast Venture Capital Association 2015 Expo on February 24th
Miami Lakes, FL – February 12, 2015 – Asana Medical, Inc., (“Asana”, the “Company”) an early stage medical device company focused on the development and commercialization of its innovative engineered tissue therapy for ulcerative colitis (“UC”), is pleased to announce that they will be exhibiting at the Gold Coast Venture Capital Association (“GCVCA”) 2015 Expo in Boca Raton, Florida on February 24th. Chief Executive Officer Marc Ramer will represent Asana Medical at the Expo.
Approximately 5.7 million people worldwide suffer from ulcerative colitis, a disease characterized by recurring episodes of inflammation of the colon lining (mucosa). Typical UC symptoms include pain, chronic diarrhea, bleeding, and urgency to use the restroom. More severe symptoms include malnutrition, stunted growth (in pediatric cases), and a greatly increased risk of colon cancer. There is no known cure for ulcerative colitis.
Asana Medical, Inc. is currently focusing its resources on the development of a device to treat UC. The Company’s solution is to leverage extracellular matrix, a proven tissue engineering technology, to the gastrointestinal space. This technology has been commercialized for over a decade and has been safely used in many clinical applications to treat millions of patients.
Asana is confident that its unique engineered tissue material, ExtraCellular Matrix Hydrogel (ECMH), can be used to coat and protect the colon in ulcerative colitis patients, allowing the body to heal the inflamed tissue. Asana’s device offers a drug-free, surgery-free alternative on a proven and safe therapy that targets the multi-billion dollar ulcerative colitis market.
In November 2014, Asana Medical was awarded $250,000 as one of eleven finalists in 43North’s Business Plan Competition. The competition, held in Buffalo, NY, attracted 6,932 entrants from around the world.
ABOUT GCVCA EXPO 2015
The GCVCA’s Expo 2015 will be held at the Embassy Suites in Boca Raton and will feature approximately 70 exhibitors, half of which will be start-ups and early stage companies from throughout the state of Florida and beyond while the other half will be corporate sponsors of relevance to the regional entrepreneurial community. Organizers expect 600-1,000 investors, entrepreneurs and premium service providers to attend. In addition to the exposition, EXPO 2015 will feature two panels on topics of interest to entrepreneurs and investors alike. For more information, visit http://www.gcvcaexpo.org.
ABOUT ASANA MEDICAL, INC.
Asana Medical, Inc. is a regenerative medicine company developing a tissue engineered therapy for the treatment of Ulcerative Colitis (UC). The Company’s product ECMH, a novel application of a proven technology, will be a first-in-class therapy for patients suffering from Ulcerative Colitis. This therapy will be positioned to compete in a multi-billion-dollar market dominated by biologic and drug therapies that can have significant side effects. Additionally, 20-30% of patients do not benefit from these therapies and have no alternative except colon removal surgery. Asana has an experienced management team, strong patent protection, world-class advisors in business and medicine, and compelling preclinical proof-of-concept data. For more information, visit www.asanamedical.com.
Executive Vice President
Asana Medical, Inc.
6135 NW 167 Street, Suite E15
Miami Lakes, FL 33015
Tel: (844) 432-7262 Ext 102